QRG Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Buy
36,743
+12,014
+49% +$5.77M 0.15% 127
2026
Q1
$12.2M Buy
24,729
+3,133
+15% +$1.7M 0.13% 156
2025
Q4
$12.5M Buy
21,596
+8,653
+67% +$4.89M 0.14% 142
2025
Q3
$6.28M Sell
12,943
-8,990
-41% -$4.18M 0.08% 211
2025
Q2
$8.89M Sell
21,933
-22,874
-51% -$9.56M 0.08% 222
2025
Q1
$22.3M Buy
44,807
+6,670
+17% +$3.61M 0.23% 93
2024
Q4
$19.8M Sell
38,137
-5,695
-13% -$3.13M 0.2% 107
2024
Q3
$27.1M Buy
43,832
+16,090
+58% +$9.52M 0.29% 76
2024
Q2
$15.3M Buy
27,742
+1,837
+7% +$1.05M 0.18% 118
2024
Q1
$15.1M Buy
25,905
+224
+0.9% +$126K 0.19% 118
2023
Q4
$13.6M Buy
25,681
+208
+0.8% +$101K 0.2% 115
2023
Q3
$12.9M Buy
+25,473
New +$13.6M 0.22% 109

Other funds holding TMO

QRG Capital Management's TMO Position: Q2 2026 in Review

QRG Capital Management increased its Thermo Fisher Scientific (TMO) stake by 49% in Q2 2026, buying an estimated $5.77M and bringing the position to 36,743 shares worth $18.4M. The position accounts for 0.15% of the portfolio, ranked #127.

QRG Capital Management first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $27.1M in Q3 2024. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • QRG Capital Management held 36,743 shares of Thermo Fisher Scientific worth $18.4M as of Q2 2026.
  • QRG Capital Management bought 12,014 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.77M.
  • Thermo Fisher Scientific made up 0.15% of QRG Capital Management's portfolio in Q2 2026, its #127 holding.
  • QRG Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Thermo Fisher Scientific position peaked at $27.1M in Q3 2024.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.